AceVector reduced the fresh issue by ₹13 Cr from the ₹300 Cr proposed in its UDRHP after raising the same amount through a ...

Nothing is hiving off CMF into a standalone Indian company, which will be Indian-owned and equipped with its own local team ...

Snapdeal parent AceVector Limited’s restated net loss declined nearly 64% to ₹45.5 Cr in FY26 from ₹126.3 Cr in the year ago ...

From mass-premium homeware to more design-led propositions, brands are carving out different positions to woo a crowded ...

CMF was launched by Nothing in 2023, and its India entity was incorporated in December 2025 with ROC Delhi CMF will now ...

Moneyview reported a 158.8% jump in its consolidated profit to ₹173.8 Cr in Q1 FY27 from ₹67.2 Cr in the year-ago quarter ...

Snapdeal-parent AceVector Ltd has filed its red herring prospectus (RHP) with the SEBI, nearly a year after receiving the markets regulator's observations on its confidential IPO filing.

EV-focused NBFC Ascend Capital’s AUM grew 46% to ₹238.6 Cr in FY26 as the lender scaled its commercial EV financing business across India.

Thyrocare Technologies approved the sale of its entire stake in Nueclear Healthcare Ltd to Trovera Healthcare for about ₹141.4 Cr ...

ADIA held held 16.98 Cr shares or 9.77% stake in Lenskart as of June 30, 2026, implying today’s deal represents a 20% reduction in its stake.

It must now complete the last formalities like submitting a listing application and an updated Final Information Memorandum within 45 days.

Moneyview has set a ₹32–₹34 share price band for its ₹1,092 Cr IPO, valuing the fintech unicorn at up to ₹5,985 Cr.